Predicting Clinical Decline and Conversion to Alzheimer’s Disease or Dementia Using Novel Elecsys Aβ(1–42), pTau and tTau CSF Immunoassays

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-54204-z

Related search